Protalix BioTherapeutics Cost of Goods Sold 2010-2024 | PLX
Protalix BioTherapeutics cost of goods sold from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.